Among 35,864 United Kingdom residents, every one-year increase in retinal age, assessed by retinal microvasculature changes, was associated with a 10% higher risk of incident kidney failure over 11 years of follow-up.
There is a pressing need to identify early predictive biomarkers of kidney failure, given its associated substantial morbidity and mortality. Ageing biomarkers have been associated with kidney failure but their clinical application has been challenging. In this study recently published in the American Journal of Kidney Diseases (AJKD), retinal age gap (retina-predicted age minus chronological age), a clinically validated and artificial intelligence powered ageing biomarker based on retinal imaging, was associated with the future risk of kidney failure among UK residents.
This non-invasive and ageing biomarker may hold promise to assist in the identification of people at elevated risk for kidney failure.
Reference:
Shiran Zhang, Ruiye Chen, Yan Wang, Wenyi Hu, Katerina V. Kiburg, Junyao Zhang, Xiaohong Yang, Honghua Yu, Mingguang He, Wei Wang, Zhuoting Zhu, Published:December 05, 2022. DOI:https://doi.org/10.1053/j.ajkd.2022.09.018
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!